ASX:NXS Next Science (NXS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Next Science Stock (ASX:NXS) 30 days 90 days 365 days Advanced Chart Get Next Science alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume86,564 shsAverage VolumeN/AMarket Capitalization$22.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNext Science Limited engages in the research, development, and commercialization of technologies that address the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial gel that conforms to the postoperative wound; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia.Read More… Receive NXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Next Science and its competitors with MarketBeat's FREE daily newsletter. Email Address NXS Stock News HeadlinesNext Science Reports Q1 FY25 Sales Decline Amid FDA Compliance EffortsApril 23 at 7:37 PM | tipranks.comNext Science Limited Updates Corporate Governance StatementApril 17, 2025 | tipranks.comTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at record pace. Why massive amounts of gold are being moved between countries. Why governments are repositioning their gold reserves. But here's what most people miss, the second pattern: During these resets, a unique anomaly appears in certain gold mining stocks. I call it the "Golden Anomaly."April 24, 2025 | Golden Portfolio (Ad)TIGA Trading Increases Stake in Next ScienceMarch 3, 2025 | tipranks.comNext Science Full Year 2024 Earnings: EPS Beats Expectations, Revenues LagMarch 2, 2025 | finance.yahoo.comNext Science Limited Reports Revenue Growth and Reduced Loss for 2024February 27, 2025 | tipranks.comNext Science sinks after FDA warning letter implies product could have caused injuryFebruary 24, 2025 | msn.comNext Science Receives FDA Warning Letter Over Compliance IssuesFebruary 24, 2025 | tipranks.comSee More Headlines NXS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Next Science own? Based on aggregate information from My MarketBeat watchlists, some other companies that Next Science investors own include Abbott Laboratories (ABT), iShares ESG Aware MSCI EM ETF (ESGE), AbbVie (ABBV), Goldman Sachs Physical Gold ETF (AAAU), Argo Investments (ARG), Arcturus Therapeutics (ARCT) and Appen (APX). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:NXS CIKN/A Webwww.nextscience.com Phone61 2 8607 5124FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,500,000.00 Net Margins-58.05% Pretax MarginN/A Return on Equity-139.08% Return on Assets-71.39% Debt Debt-to-Equity Ratio11.67 Current Ratio2.17 Quick Ratio4.80 Sales & Book Value Annual Sales$23.31 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow17.23 Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares292,160,000Free FloatN/AMarket Cap$22.99 million OptionableNot Optionable Beta1.43 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (ASX:NXS) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Next Science Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Next Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NXS Stock Free NXS Stock Alerts